News & Updates

Show Multimedia Only

Can community pharmacists identify gaps in statin use for ASCVD prevention?

12 Mar 2026

Community pharmacists can effectively recognize treatment gaps in the use of statin therapy for the prevention of atherosclerotic cardiovascular disease (ASCVD) events, suggests a recent study.

Can community pharmacists identify gaps in statin use for ASCVD prevention?

12 Mar 2026

RW data support enfortumab vedotin-pembrolizumab combo as 1L Tx for bladder cancer

12 Mar 2026 by

Real-world (RW) data presented at ASCO GU 2026 support the use of enfortumab vedotin plus pembrolizumab (EV+P) as frontline treatment for advanced urothelial carcinoma (UC).

RW data support enfortumab vedotin-pembrolizumab combo as 1L Tx for bladder cancer

12 Mar 2026

Belzutifan-lenvatinib bests cabozantinib for RCC

11 Mar 2026 by

A combination regimen comprising belzutifan and lenvatinib outdoes cabozantinib alone for the treatment of advanced clear cell renal cell carcinoma (ccRCC) in the phase III LITESPARK-011 study.

Belzutifan-lenvatinib bests cabozantinib for RCC

11 Mar 2026

Angiotensin-II stimulating agents associated with lower burden of key AD neuropathologies

11 Mar 2026 by

Cumulative angiotensin II–stimulating (vs angiotensin II–inhibiting) antihypertensive exposure is associated with lower risk of certain dementia-related neuropathologies, a US study has found.

Angiotensin-II stimulating agents associated with lower burden of key AD neuropathologies

11 Mar 2026

Tafamidis beneficial in geriatric transthyretin cardiac amyloidosis

10 Mar 2026

Treatment with the transthyretin stabilizer tafamidis helps lower mortality and reduce hospital readmissions for acute heart failure in octogenarian patients with transthyretin cardiac amyloidosis, as shown in a study.

Tafamidis beneficial in geriatric transthyretin cardiac amyloidosis

10 Mar 2026

RSV-related infant hospitalization outcomes post-nirsevimab or RSVpreF immunization: Evidence from a French cohort study

10 Mar 2026 by

Preventing respiratory syncytial virus (RSV) in infants can be achieved through maternal vaccination with the RSV prefusion F protein (RSVpreF) vaccine or administration of the monoclonal antibody nirsevimab—strategies endorsed by the WHO. In a French population-based cohort study, nirsevimab has been associated with lower risks of RSV-related hospitalizations and severe outcomes.

RSV-related infant hospitalization outcomes post-nirsevimab or RSVpreF immunization: Evidence from a French cohort study

10 Mar 2026

Novel drug safe, efficacious in patients with HDV-related advanced liver disease

10 Mar 2026

Treatment with REP 2139-Mg (REP), a nucleic acid polymer, demonstrates efficacy and an acceptable safety profile among patients with hepatitis D virus (HDV) and advanced chronic liver disease (CLD), reports a recent study.

Novel drug safe, efficacious in patients with HDV-related advanced liver disease

10 Mar 2026

Oral interleukin-1β blocker makes no difference in knee osteoarthritis

10 Mar 2026

Treatment with the oral interleukin-1β blocker diacerein appears minimally beneficial for reducing pain in patients with knee osteoarthritis (OA), as shown in a study.

Oral interleukin-1β blocker makes no difference in knee osteoarthritis

10 Mar 2026

Nifedipine as good as labetalol for managing hypertension during pregnancy

10 Mar 2026 by

Treatment with either nifedipine or labetalol is equally effective in controlling blood pressure (BP) among women with hypertension during pregnancy, with no adverse effects on perinatal outcomes, according to the Giant PANDA* trial presented at SMFM 2026.

Nifedipine as good as labetalol for managing hypertension during pregnancy

10 Mar 2026

Finerenone shows promise for restoring fertility in premature ovarian insufficiency

10 Mar 2026 by

In patients with premature ovarian insufficiency (POI), finerenone, a drug approved for slowing progressive kidney function decline associated with type 2 diabetes, can promote the development of follicles into mature oocytes yielding viable embryos, according to breakthrough findings by researchers from the University of Hong Kong (HKU).

Finerenone shows promise for restoring fertility in premature ovarian insufficiency

10 Mar 2026

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Can community pharmacists identify gaps in statin use for ASCVD prevention?

Can community pharmacists identify gaps in statin use for ASCVD prevention?

RW data support enfortumab vedotin-pembrolizumab combo as 1L Tx for bladder cancer

RW data support enfortumab vedotin-pembrolizumab combo as 1L Tx for bladder cancer

Belzutifan-lenvatinib bests cabozantinib for RCC

Belzutifan-lenvatinib bests cabozantinib for RCC

Angiotensin-II stimulating agents associated with lower burden of key AD neuropathologies

Angiotensin-II stimulating agents associated with lower burden of key AD neuropathologies

Tafamidis beneficial in geriatric transthyretin cardiac amyloidosis

Tafamidis beneficial in geriatric transthyretin cardiac amyloidosis

RSV-related infant hospitalization outcomes post-nirsevimab or RSVpreF immunization: Evidence from a French cohort study

RSV-related infant hospitalization outcomes post-nirsevimab or RSVpreF immunization: Evidence from a French cohort study

Novel drug safe, efficacious in patients with HDV-related advanced liver disease

Novel drug safe, efficacious in patients with HDV-related advanced liver disease

Oral interleukin-1β blocker makes no difference in knee osteoarthritis

Oral interleukin-1β blocker makes no difference in knee osteoarthritis

Nifedipine as good as labetalol for managing hypertension during pregnancy

Nifedipine as good as labetalol for managing hypertension during pregnancy

Finerenone shows promise for restoring fertility in premature ovarian insufficiency

Finerenone shows promise for restoring fertility in premature ovarian insufficiency